Literature DB >> 3943896

Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.

M W Reeves, R J Arko, F W Chandler, N B Bridges.   

Abstract

Toxic shock syndrome toxin 1 (TSST-1) was purified to apparent homogeneity by chromatofocusing and affinity chromatography. The amino acid composition of the toxin was very similar to that reported for TSST-1 by other investigators. The amino-terminal amino acid was serine. A partial specific volume of 0.73 ml/g was calculated for the toxin from the amino acid data, and a molecular weight of 19,200 +/- 1,300 was determined by hydrodynamic methods. New Zealand white rabbits of both sexes were equally susceptible to the lethal effects of the toxin; however, older rabbits (greater than 12 months) were far more susceptible than young adults or weanlings. The 50% lethal dose of TSST-1 in older rabbits was 50 to 60 micrograms/kg when injected subcutaneously and 20 to 30 micrograms/kg when injected intravenously. Enhancement of lethal endotoxin shock by TSST-1 could not be demonstrated when both toxins were injected subcutaneously; however, lethal shock did occur when endotoxin (10 micrograms/kg) was injected intravenously after TSST-1 had been injected by either the subcutaneous (50 to 60 micrograms/kg) or the intravenous (20 to 30 micrograms/kg) route. Endotoxin alone was not lethal at a dose of 500 micrograms/kg of body weight when injected subcutaneously. When injected intravenously, endotoxin at a dose of 500 micrograms/kg was not lethal in weanling males or in females in any age group; however, young (6 to 7 months) and adult (greater than 12 months) males were killed by endotoxin doses as low as 45 to 50 micrograms/kg. Histopathologic studies of rabbits by both sexes which died as a result of TSST-1 alone or in combination with endotoxin showed extensive damage to organs rich in lymphoid and mononuclear phagocytic cells such as the thymus, mesenteric lymph nodes, liver, and spleen. Severe congestion of these organs as well as erythrophagocytosis and lymphoid depletion in the spleen and mesenteric lymph nodes were noted. Congestion and hemorrhage were also found in the heart, lungs, trachea, and thymus. The systemic pathology produced by TSST-1 was strikingly similar to that seen in humans who had died of toxic shock syndrome and in rabbits with subcutaneous chamber inoculated with toxic shock case strains of Staphylococcus aureus. Rabbits that were not killed by the toxin suffered a very rapid and severe leukopenia followed by leukocytosis with a left shift. Lymphopenia was also noted as was a mild but persistent anemia. With the exception of the early leukopenia, very similar hematologic findings have been noted in humans with toxic shock syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943896      PMCID: PMC262347          DOI: 10.1128/iai.51.2.431-439.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

Authors:  V C Tsang; J M Peralta; A R Simons
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Clinical manifestations of toxic shock syndrome.

Authors:  P J Chesney; J P Davis; W K Purdy; P J Wand; R W Chesney
Journal:  JAMA       Date:  1981-08-14       Impact factor: 56.272

5.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

6.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

7.  Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention.

Authors:  J P Davis; P J Chesney; P J Wand; M LaVenture
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

8.  Toxic shock syndrome: a retrospective study of 25 cases from Iowa.

Authors:  C M Helms; R W Lengeling; R L Pinsky; M G Myers; F P Koontz; L W Klassen; L A Wintermeyer
Journal:  Am J Med Sci       Date:  1981 Sep-Oct       Impact factor: 2.378

9.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

10.  Clinical and laboratory manifestations of toxic shock syndrome.

Authors:  R W Tofte; D N Williams
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

View more
  8 in total

Review 1.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.

Authors:  A Zembowicz; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1.

Authors:  W W Kum; K B Laupland; R H See; A W Chow
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

4.  Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.

Authors:  P F Bonventre; M R Thompson; L E Adinolfi; Z A Gillis; J Parsonnet
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1.

Authors:  J Parsonnet; Z A Gillis; A G Richter; G B Pier
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome.

Authors:  J M Musser; P M Schlievert; A W Chow; P Ewan; B N Kreiswirth; V T Rosdahl; A S Naidu; W Witte; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 7.  The systemic and pulmonary immune response to staphylococcal enterotoxins.

Authors:  Sanjeev Kumar; Antoine Ménoret; Soo-Mun Ngoi; Anthony T Vella
Journal:  Toxins (Basel)       Date:  2010-07-21       Impact factor: 4.546

8.  Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

Authors:  C Jupin; S Anderson; C Damais; J E Alouf; M Parant
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.